Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Suyash Prasad currently holds 530,589 shares of Taysha Gene Therapies, Inc. (TSHA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Suyash Prasad has been a net seller of TSHA stock. They have purchased $0 and sold $4.1M worth of shares.
Suyash Prasad's most recent insider trade was on Jul 6, 2022, when they sold 8,956 shares at $3.79 per share.
Suyash Prasad serves as Executive at Taysha Gene Therapies, Inc. (TSHA). They have executed 48 insider transactions totaling $4.1M over their tenure at the company.
Suyash Prasad holds the position of Executive at Taysha Gene Therapies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Suyash Prasad has shown a selling trading pattern, with $0 in total purchases and $4.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Suyash Prasad was on Jun 29, 2021, when they sold $832.2K worth of TSHA shares. This transaction involved 35,056 shares at $23.74 per share.
Suyash Prasad currently owns 530,589 shares of Taysha Gene Therapies, Inc. (TSHA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Suyash Prasad's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Suyash Prasad has 48 Form 4 filings on record as an insider at Taysha Gene Therapies, Inc..
Set alerts for Suyash Prasad and 40,000+ other insiders.